Company page
Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc. is a public company listed under the ticker ACAD, operating in the American market. The company has a market capitalization of approximately $3.7 billion. Acadia focuses on developing innovative therapies for neurological and psychiatric disorders.
- Ticker
- ACAD:NASDAQ
- Asset type
- Stock
- Market cap
- $3.70B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD